GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (FRA:8NN) » Definitions » Price-to-Free-Cash-Flow

Thor Medical ASA (FRA:8NN) Price-to-Free-Cash-Flow : N/A (As of May. 23, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA Price-to-Free-Cash-Flow?

As of today (2025-05-23), Thor Medical ASA's share price is €0.2075. Thor Medical ASA's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.01. Hence, Thor Medical ASA's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Thor Medical ASA's Price-to-Free-Cash-Flow or its related term are showing as below:

FRA:8NN's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.2
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Thor Medical ASA's Free Cash Flow per Share for the six months ended in Dec. 2024 was €-0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €-0.01.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 70.90% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 56.80% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 20.70% per year.

During the past 13 years, Thor Medical ASA's highest 3-Year average Free Cash Flow per Share Growth Rate was 70.90% per year. The lowest was -99.20% per year. And the median was -10.20% per year.


Thor Medical ASA Price-to-Free-Cash-Flow Historical Data

The historical data trend for Thor Medical ASA's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thor Medical ASA Price-to-Free-Cash-Flow Chart

Thor Medical ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Thor Medical ASA Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Thor Medical ASA's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Thor Medical ASA's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thor Medical ASA's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's Price-to-Free-Cash-Flow falls into.


;
;

Thor Medical ASA Price-to-Free-Cash-Flow Calculation

Thor Medical ASA's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.2075/-0.009
=N/A

Thor Medical ASA's Share Price of today is €0.2075.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Thor Medical ASA's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Thor Medical ASA  (FRA:8NN) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Thor Medical ASA Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Thor Medical ASA Business Description

Traded in Other Exchanges
Address
Karenslyst Alle 9C, Oslo, NOR, 0278
Thor Medical ASA is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells.

Thor Medical ASA Headlines

No Headlines